| Primary |
| Drug Use For Unknown Indication |
16.2% |
| Urinary Tract Infection |
16.2% |
| Hypertension |
7.7% |
| Bacteraemia |
6.2% |
| Pneumonia Mycoplasmal |
5.4% |
| Sinusitis |
5.4% |
| Ear Infection |
3.8% |
| Osteomyelitis |
3.8% |
| Product Used For Unknown Indication |
3.8% |
| Bronchitis |
3.1% |
| Infection |
3.1% |
| Kidney Infection |
3.1% |
| Lower Respiratory Tract Infection |
3.1% |
| Mycobacterium Ulcerans Infection |
3.1% |
| Prophylaxis |
3.1% |
| Sepsis |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Antibiotic Therapy |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Diverticulitis |
2.3% |
|
| Rash |
8.5% |
| Renal Failure Acute |
8.5% |
| Tendon Rupture |
8.5% |
| Pain In Extremity |
6.4% |
| Urinary Tract Infection |
6.4% |
| Vertigo |
6.4% |
| Balance Disorder |
4.3% |
| Drug Interaction |
4.3% |
| Gastroenteritis Clostridial |
4.3% |
| Gastroenteritis Viral |
4.3% |
| Rotator Cuff Syndrome |
4.3% |
| Stevens-johnson Syndrome |
4.3% |
| Supraventricular Tachycardia |
4.3% |
| Tendonitis |
4.3% |
| Toxic Epidermal Necrolysis |
4.3% |
| Treatment Failure |
4.3% |
| Tremor |
4.3% |
| Vision Blurred |
4.3% |
| Abnormal Palmar/plantar Creases |
2.1% |
| Anaemia |
2.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
22.5% |
| Product Used For Unknown Indication |
14.9% |
| Type 2 Diabetes Mellitus |
7.2% |
| Bronchopulmonary Aspergillosis |
6.4% |
| Osteomyelitis |
6.4% |
| Pneumonia |
6.4% |
| Urinary Tract Infection |
5.6% |
| Pyrexia |
4.4% |
| Wound Infection |
4.0% |
| Oedema |
3.2% |
| Hypertension |
2.8% |
| Mantle Cell Lymphoma |
2.8% |
| Pain |
2.8% |
| Animal Bite |
1.6% |
| Catheter Placement |
1.6% |
| Infection |
1.6% |
| Nausea |
1.6% |
| Sinusitis |
1.6% |
| Acute Myeloid Leukaemia |
1.2% |
| Liver Transplant Rejection |
1.2% |
|
| Hepatic Enzyme Increased |
20.6% |
| Renal Failure Acute |
8.8% |
| Osteoarthritis |
5.9% |
| Pseudomembranous Colitis |
5.9% |
| Rash |
5.9% |
| Renal Failure |
5.9% |
| Renal Failure Chronic |
5.9% |
| Toxic Epidermal Necrolysis |
5.9% |
| Abdominal Distension |
2.9% |
| Agitation |
2.9% |
| Brain Oedema |
2.9% |
| Decreased Appetite |
2.9% |
| Dermatitis Exfoliative |
2.9% |
| Diarrhoea |
2.9% |
| Disturbance In Social Behaviour |
2.9% |
| Dizziness |
2.9% |
| Febrile Bone Marrow Aplasia |
2.9% |
| Hemiplegia |
2.9% |
| Hepatic Necrosis |
2.9% |
| Hyperbilirubinaemia |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.6% |
| Product Used For Unknown Indication |
20.4% |
| Multiple Myeloma |
5.5% |
| Crohn's Disease |
4.5% |
| Prophylaxis |
4.4% |
| Pain |
3.4% |
| Breast Cancer |
2.9% |
| Hodgkin's Disease |
2.9% |
| Hypertension |
2.7% |
| Diffuse Large B-cell Lymphoma |
2.5% |
| Pneumonia |
2.5% |
| Acute Myeloid Leukaemia |
2.4% |
| Depression |
2.2% |
| Anxiety |
1.9% |
| Pyrexia |
1.7% |
| Contraception |
1.6% |
| Nuclear Magnetic Resonance Imaging |
1.6% |
| Hiv Infection |
1.5% |
| Infection |
1.5% |
| Non-small Cell Lung Cancer |
1.5% |
|
| Vomiting |
15.1% |
| Weight Decreased |
9.7% |
| Nausea |
7.5% |
| Sepsis |
6.5% |
| Pulmonary Embolism |
5.4% |
| Pyrexia |
5.4% |
| White Blood Cell Count Decreased |
5.4% |
| Stomatitis |
4.3% |
| Thrombocytopenia |
4.3% |
| Urinary Tract Infection |
4.3% |
| Abdominal Pain |
3.2% |
| Dermatitis Exfoliative |
3.2% |
| Dyspnoea |
3.2% |
| Incorrect Dose Administered |
3.2% |
| Pneumonia |
3.2% |
| Renal Failure Acute |
3.2% |
| Staphylococcal Infection |
3.2% |
| Syncope |
3.2% |
| Type 2 Diabetes Mellitus |
3.2% |
| Weight Increased |
3.2% |
|
| Interacting |
| Cystitis |
42.9% |
| Liver Transplant Rejection |
21.4% |
| Drug Use For Unknown Indication |
14.3% |
| Infection |
14.3% |
| Epilepsy |
7.1% |
|
| Metrorrhagia |
50.0% |
| Dizziness |
25.0% |
| Drug Interaction |
25.0% |
|
